Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18,360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to MEK Inhibitor Therapy in MAP2K1 (MEK1) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of MAP2K1 Mutations in Non-Small-Cell Lung Cancer.
Cheng ML, Lee JK, Kumar R, Klein H, Raskina K, Schrock AB, Michael KS, Mazor T, Cerami E, Oxnard GR, Liu D, Beltran H, Sholl LM, Nishino M, Jänne PA. Cheng ML, et al. Among authors: kumar r. JCO Precis Oncol. 2022 Nov;6:e2200382. doi: 10.1200/PO.22.00382. JCO Precis Oncol. 2022. PMID: 36455195 No abstract available.
Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP) is associated with improvement in weight and components of metabolic syndrome in men exposed to androgen deprivation therapy for prostate cancer.
Algotar AM, Hsu CH, Chow HH, Dougherty ST, Babiker HM, Marrero DG, Abraham I, Kumar R, Ligibel JA, Courneya KS, Smith TE, Jones PA, Lopez JN, Niemiro G, Ramakumar S, Hoy RD, Mack C, Thomson CA. Algotar AM, et al. Among authors: kumar r. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):903-909. doi: 10.1038/s41391-021-00346-z. Epub 2021 Mar 25. Prostate Cancer Prostatic Dis. 2021. PMID: 33767355
Protocol for a feasibility and early efficacy study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2).
Algotar AM, Kumar R, Babiker HM, Dougherty ST, Hsu CH, Chow HH, Smith TE, Marrero DG, Courneya KS, Abraham I, Ligibel JA, Thomson CA. Algotar AM, et al. Among authors: kumar r. Contemp Clin Trials Commun. 2021 Jan 13;21:100701. doi: 10.1016/j.conctc.2021.100701. eCollection 2021 Mar. Contemp Clin Trials Commun. 2021. PMID: 33511299 Free PMC article.
Approaches in Managing Resistant Hypertension: A Review.
Mittal S, Jain P, Sharma R, Ponde CK, Routray S, Chopra S, Kumar R, Naqvi S, Mittal R. Mittal S, et al. Among authors: kumar r. Cureus. 2024 Apr 8;16(4):e57804. doi: 10.7759/cureus.57804. eCollection 2024 Apr. Cureus. 2024. PMID: 38721164 Free PMC article. Review.
18,360 results
You have reached the last available page of results. Please see the User Guide for more information.